FdaApplication
NDA 214275
Identifiers
- fda_app_no: NDA214275
Properties
| Property | Value |
|---|---|
| applicant_name | ACTELION PHARMACEUTICALS US INC |
| application_type | NDA |
| approval_date | 2021-07-29 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| UPTRAVI | SELEXIPAG | 1.8MG/VIAL | POWDER;INTRAVENOUS |
1 product